Frequency and severity of COVID‐19 in patients with various rheumatic diseases treated regularly with colchicine or hydroxychloroquineMert Öztaş, Serdal Uğurlu, Ayten Dağ et al.|Journal of Medical Virology|2022Cited by 8
Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controlsAli Mert, Ahmet Gül, Haluk Vahaboğlu et al.|Rheumatology International|2021Cited by 6